Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 2/2012

01-09-2012 | CE - LETTER TO THE EDITOR

TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis

Authors: Matteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, Raffaele Scarpa, Giovanni Di Minno

Published in: Internal and Emergency Medicine | Special Issue 2/2012

Login to get access

Excerpt

To the Editor: …
Literature
1.
Tam LS, Li EK, Shang Q et al (2011) Tumor necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study. Ann Rheum Dis 70:705–706PubMedCrossRef
2.
Di Minno MND, Iervolino S, Peluso R et al (2011) Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α (TNF-α)-blockers and traditional disease modifying anti-rheumatic drugs. Arterioscler Thromb Vasc Biol 31:705–712PubMedCrossRef
3.
Benagiano M, Azzurri A, Ciervo A et al (2003) T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci USA 100:6658–6663PubMedCrossRef
4.
Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467PubMedCrossRef
5.
Coates LC, Cook R, Leeka KA et al (2010) Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res 62:970–976CrossRef
Metadata
Title
TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis
Authors
Matteo Nicola Dario Di Minno
Salvatore Iervolino
Rosario Peluso
Raffaele Scarpa
Giovanni Di Minno
Publication date
01-09-2012
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue Special Issue 2/2012
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0704-6

Other articles of this Special Issue 2/2012

Internal and Emergency Medicine 2/2012 Go to the issue

CE - LETTER TO THE EDITOR

An over-the-counter weight-loss supplement with a toxicity that may be unexpectedly difficult to treat

CE - MEDICAL ILLUSTRATION

Chest ultrasonography to detect lung involvement in Von Recklinghausen’s disease

CE - MEDICAL ILLUSTRATION

Emergency management of puerperal breast abscess

CE - MEDICAL ILLUSTRATION

Incarcerated Morgagni hernia mimicking acute cholecystitis

CE - MEDICAL ILLUSTRATION

Edematous striae distensae

CE - LETTER TO THE EDITOR

The emergency physician and the prompt management of severe hyperkalemia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits